Trial · NCT07914270
Aquatic Power Training Dosing Strategies and Creatine Supplementation in Older Adults
NCT07914270, Not applicable, Recruiting, University of Valencia
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Aquatic Power Training Dosing Strategies and Creatine Supplementation in Older Adults. Trials, record NCT07914270. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07914270
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Aquatic Power Training Dosing Strategies and Creatine Supplementation in Older Adults
- NCT number
- NCT07914270
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 100 participants, estimated
- Lead sponsor
- University of Valencia
- Conditions
- Aging, Supplementation, Exercise
- Interventions
- RPE-1 Aquatic Power Training-Placebo, Time-Based Aquatic Power Training-Placebo, Time-Based Aquatic Power Training + Creatine, Sedentary Control + Placebo, Sedentary Control + Creatine
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes43
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Body Composition via Dual-Energy X-ray Absorptiometry (DXA) | Pre and post-intervention of 16 weeks | Whole body and segmental composition will be assessed through Dual-Energy X-ray Absorptiometry (DXA). Parameters analyzed will be: total and regional fat mass and lean mass and % of fat mass. |
| Primary | Change in handgrip strength | Pre and post-intervention of 16 weeks | Handgrip strength (Kg) will be assessed using hand-held dynamometry. Higher values indicate greater muscle strength |
| Primary | Change in lower limb Isokinetic muscle strength | Pre and post-intervention of 16 weeks | knee flexo-extension muscle strength will be assessed using an isokinetic dynamometer (Biodex®) at an angular velocity of 180°/s. Peak torque will be recorded in Newton-meters (Nm), with higher values indicating greater strength |
| Primary | Change in upper limb Isokinetic muscle Strength | Pre and post-intervention of 16 weeks | Elbow flexo-extension muscle strength will be assessed using an isokinetic dynamometer (Biodex®) at an angular velocity of 180°/s. Peak torque will be recorded in Newton-meters (Nm), with higher values indicating greater strength |
| Primary | Change in functional mobility and agility performance | Pre and post-intervention of 16 weeks | Functional mobility and agility will be assessed using the Timed Up and Go Test. The time required to stand from a chair, walk the standardized distance, turn, return, and sit down will be recorded in seconds. Lower values indicate better functional performance. |
| Primary | Change in lower body functional performance | Pre and post-intervention of 16 weeks | Lower-body functional capacity (resistance strength) will be assessed using the 30-Second Chair Stand Test. The number of complete sit-to-stand repetitions performed within 30 seconds will be recorded. Higher values indicate better functional performance. |
| Primary | Change in aerobic performance | Pre and post-intervention of 16 weeks | Functional aerobic capacity will be assessed using the 6-Minute Walk Test. The total distance walked during six minutes will be recorded in meters. Higher values indicate better functional capacity. |
| Secondary | Change in bone health (bone formation) | Pre and post-intervention of 16 weeks | Serum procollagen type I N-terminal propeptide (P1NP) will be measured as a marker of bone formation. |
| Secondary | Change in bone health (bone resorption) | Pre and post-intervention of 16 weeks | Serum C-terminal telopeptide of type I collagen (β-CTX) will be measured as a marker of bone resorption |
| Secondary | Change in cardiometabolic health (systolic blood pressure) | Pre and post-intervention of 16 weeks | Resting systolic blood pressure will be assessed and expressed in millimeters of mercury (mmHg), with lower values generally indicating lower cardiovascular risk. |
1 to 10 of 43Source ClinicalTrials.gov
See all 43 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07914270
GET https://conductscience.org/api/trials/v1/NCT07914270/registered?page=2